Adequan i.m (polysulfated glycosaminoglycan) is the only FDA-approved PSGAG for degenerative joint disease (DJD) in horses. Adequan i.m. treats the disease, not just its clinical signs by reducing inflammation, restoring synovial joint lubrication, repairing joint cartilage and reversing the disease process. For over 30 years, Adequan i.m has been prescribed by veterinarians to help horses of every discipline and level enjoy greater mobility over their lifetimes. There is no generic version of Adequan i.m. Adequan i.m. (polysulfated glycosaminoglycan) is recommended for the intramuscular treatment of non-infectious degenerative and/or traumatic joint dysfunction and associated lameness of the carpal and hock joints in horses. Qualifying purchases of 7-dose series (seven 5mL vials or one 50mL vial) of Adequan Equine may be eligible for a **$20 rebate**. Learn how to claim your rebate in the FAQs below. **We directly source prescription medications from manufacturers and wholesale distributors registered with the FDA and licensed by applicable state boards. Guaranteed genuine, and where applicable, backed by the manufacturer.**